Literature DB >> 23085014

Vitamin D: health panacea or false prophet?

Michael J Glade1.   

Abstract

Vitamin D deficiency, diagnosed when the serum 25-hydroxyvitamin D (25-OHD(3)) concentration is less than 20 ng/mL, has joined vitamin A deficiency as two of the most common nutrition-responsive medical conditions worldwide. There have been more scientific articles published about vitamin D in the 21st century than about any other vitamin, reflecting the massive expansion of the field of vitamin D research. Adequate vitamin D status has been linked to decreased risks of developing specific cancers, including cancers of the esophagus, stomach, colon, rectum, gallbladder, pancreas, lung, breast, uterus, ovary, prostate, urinary bladder, kidney, skin, thyroid, and hematopoietic system (e.g., Hodgkin's lymphoma, non-Hodgkin's lymphoma, multiple myeloma); bacterial infections; rheumatoid arthritis; Crohn's disease; periodontal disease; multiple sclerosis; asthma; type 2 diabetes; cardiovascular disease; stroke; peripheral artery disease; hypertension; chronic kidney disease; muscle weakness; cognitive impairment; Alzheimer's disease; clinical depression; and premature death. On the other hand, inadequate vitamin D status during human pregnancy may be associated with increased risk for the development of type 1 diabetes in the offspring. However, this point of view may be excessively optimistic. There also is evidence that despite the current heavy reliance on serum 25-OHD(3) concentration for the diagnosis of an individual's vitamin D status, local tissue vitamin D intoxication may be present in individuals with much lower serum 25-OHD(3) concentrations than are currently appreciated. Only rarely are the symptoms of local tissue vitamin D intoxication associated with vitamin D status or intake. An individual's serum 25-OHD(3) concentration may appear to be "low" for reasons totally independent of sunlight exposure or vitamin D intake. Serum 25-OHD(3) concentration is only poorly responsive to increases in vitamin D intake, and the prolonged routine consumption of thousands of international units of vitamin D may interfere with the regulation of phosphate homeostasis by fibroblast growth factor-23 (FGF23) and the Klotho gene product, with consequences that are detrimental to human health. In light of these counterbalancing observations, curbing excessive enthusiasm for universally increasing vitamin D intake recommendations may be in order.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23085014     DOI: 10.1016/j.nut.2012.05.010

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  20 in total

1.  Vitamin D inhibits COX-2 expression and inflammatory response by targeting thioesterase superfamily member 4.

Authors:  Qingsong Wang; Yuhu He; Yujun Shen; Qianqian Zhang; Di Chen; Caojian Zuo; Jing Qin; Hui Wang; Junwen Wang; Ying Yu
Journal:  J Biol Chem       Date:  2014-03-10       Impact factor: 5.157

2.  Can vitamin D status be assessed by serum 25OHD in children?

Authors:  María Agustina Alonso; Zamir Francisco Pallavicini; Julián Rodríguez; Noelia Avello; Pablo Martínez-Camblor; Fernando Santos
Journal:  Pediatr Nephrol       Date:  2014-08-20       Impact factor: 3.714

3.  The Three Sisters of Fate in Multiple Sclerosis: Klotho (Clotho), Fibroblast Growth Factor-23 (Lachesis), and Vitamin D (Atropos).

Authors:  Hamit Yasar Ellidag; Necat Yilmaz; Fatma Kurtulus; Ozgur Aydin; Esin Eren; Ayca Inci; Suleyman Dolu; Fatma Demet Arslan Ince; Özlem Giray; Aylin Yaman
Journal:  Ann Neurosci       Date:  2016-09-09

4.  The correlation between the vitamin A, D, and E levels and recurrent respiratory tract infections in children of different ages.

Authors:  Wenqiu Tian; Wenxia Yi; Jing Zhang; Mei Sun; Rongrong Sun; Zhixin Yan
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

Review 5.  Vitamin D and Genetic Susceptibility to Multiple Sclerosis.

Authors:  Concetta Scazzone; Luisa Agnello; Giulia Bivona; Bruna Lo Sasso; Marcello Ciaccio
Journal:  Biochem Genet       Date:  2020-11-07       Impact factor: 1.890

Review 6.  Potential pathophysiological role for the vitamin D deficiency in essential hypertension.

Authors:  Federico Carbone; François Mach; Nicolas Vuilleumier; Fabrizio Montecucco
Journal:  World J Cardiol       Date:  2014-05-26

7.  Vitamin D Levels and Sociodemographic and Clinical Correlates in Individuals With Serious Mental Illness Admitted to an Acute Psychiatry Unit.

Authors:  Lakshminarayana Chekuri; Purushottam B Thapa; Carolyn L Turturro; Dinesh Mittal; Erick Messias
Journal:  Prim Care Companion CNS Disord       Date:  2015-04-30

8.  Prevalence of vitamin D deficiency and its association with nutrition, travelling and clothing habits in an immigrant population in Northern Sweden.

Authors:  L Granlund; A Ramnemark; C Andersson; M Lindkvist; E Fhärm; M Norberg
Journal:  Eur J Clin Nutr       Date:  2015-10-28       Impact factor: 4.016

9.  PLGA nanoparticles as a platform for vitamin D-based cancer therapy.

Authors:  Maria J Ramalho; Joana A Loureiro; Bárbara Gomes; Manuela F Frasco; Manuel A N Coelho; M Carmo Pereira
Journal:  Beilstein J Nanotechnol       Date:  2015-06-12       Impact factor: 3.649

Review 10.  Reviewing the Significance of Vitamin D Substitution in Monoclonal Gammopathies.

Authors:  Vanessa Innao; Alessandro Allegra; Lia Ginaldi; Giovanni Pioggia; Massimo De Martinis; Caterina Musolino; Sebastiano Gangemi
Journal:  Int J Mol Sci       Date:  2021-05-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.